X

Healthcare

Max Healthcare Inst. Limited Q3FY23 Earnings

Primary care clinics, multi-specialty hospitals / medical centres, and super-specialty hospitals are the main venues through which Max Healthcare Institute…

Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Transcript

Orchid Pharma Ltd (NSE: ORCHPHARMA) Q3 FY23 Earnings Concall dated Feb. 17, 2023 Corporate Participants: Manish Dhanuka -- Managing Director Mridul Dhanuka -- Executive…

Shilpa Medicare Ltd (SHILPAMED) Q3 FY23 Earnings Concall Transcript

Shilpa Medicare Ltd (NSE: SHILPAMED) Q3 FY23 Earnings Concall dated Feb. 15, 2023 Corporate Participants: Vishnukanth Bhutada -- Managing Director Alpesh Dalal -- Chief…

Aster DM Healthcare Limited (ASTERDM) Q3 FY23 Earnings Concall Transcript

Aster DM Healthcare Limited (NSE:ASTERDM) Q3 FY23 Earnings Concall dated Feb. 15, 2023. Corporate Participants: Azad Moopen -- Chairman and Managing Director…

Fortis Healthcare Ltd (FORTIS) Q3 FY23 Earnings Concall Transcript

Fortis Healthcare Ltd (NSE:FORTIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Anurag Kalra -- Senior Vice President, Investor Relations…

Lupin Ltd Q3 FY23 Earnings Conference Call Insights

Key highlights from Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Management Update: [00:03:30] LUPIN said it is optimistic of growing…

Lupin Ltd (LUPIN) Q3 FY23 Earnings Concall Transcript

Lupin Ltd (NSE:LUPIN) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Vinita Gupta -- Chief Executive Officer Ramesh Swaminathan -- Executive Director,…

Aurobindo Pharma Limited (AUROPHARMA) Q3 FY23 Earnings Concall Transcript

Aurobindo Pharma Limited (NSE:AUROPHARMA) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Deepti Thakur -- Investor Relations Santhanam Subramanian -- Chief Financial…

Fortis Healthcare Q3 FY23; Revenue Increased By 6% Year On Year

Fortis Healthcare Limited (NSE: FORTIS) reported a Revenue from Operations of ₹1,559.88 Crores, an increased of 6% growth from the…

Piramal Pharma Ltd (PPLPHARMA) Q3 FY23 Earnings Concall Transcript

Piramal Pharma Ltd (NSE: PPLPHARMA) Q3 FY23 Earnings Concall dated Feb. 09, 2023 Corporate Participants: Gagan Borana -- General Manager, Investor Relations…